Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans

Zhang, Xinmei, Yeung, Dennis C.Y., Karpisek, Michal, Stejskal, David, Zhou, Zhi-Guang, Liu, Feng, Wong, Rachel L.C., Chow, Wing-Sun +3 more·2008·Diabetes
DOI 10.2337/db07-1476

Cited by (907)

Items 401–500 of 907

  1. Association between Serum Fibroblast Growth Factor 21 and Coronary Artery Disease in Patients with Type 2 Diabetes
    Won Jin Kim, Sang Soo Kim, Han Cheol Lee, Sang Heon Song, Min Jung Bae, Yang Yi, Yun Kyung Jeon, Bo Hyun Kim, Yong Ki Kim, In Joo Kim · 2015 · Journal of Korean Medical Science
  2. Fasting-Induced FGF21 Is Repressed by LXR Activation via Recruitment of an HDAC3 Corepressor Complex in Mice
    Amena Archer, Nicolas Venteclef, Agneta Mode, Matteo Pedrelli, Chiara Gabbi, Karine Clément, Paolo Parini, Jan-Ακε Gustafsson, Marion Korach-André · 2012 · Molecular Endocrinology
  3. Plasma Concentrations of Fibroblast Growth Factors 21 and 19 in Patients with Cushing's Syndrome
    Viktorie Ďurovcová, J Marek, Václav Hána, Martin Matoulek, Vı́t Zikán, D Haluzíková, Petra Kaválková, Z Lacinová, Michal Kršek, Martin Haluzı́k · 2010 · Physiological Research
  4. Expression of Fibroblast Growth Factor-21 in Muscle Is Associated with Lipodystrophy, Insulin Resistance and Lipid Disturbances in Patients with HIV
    Birgitte Lindegaard, Thine Hvid, Thomas Sahl Grøndahl, Christian Frøsig, Jan Gerstoft, Pernille Højman, Bente Klarlund Pedersen · 2013 · PLoS ONE
  5. Bone Metabolism in Anorexia Nervosa
    Pouneh K. Fazeli, Anne Klibanski · 2014 · Current Osteoporosis Reports
  6. Silencing of FGF ‐21 expression promotes hepatic gluconeogenesis and glycogenolysis by regulation of the STAT 3– SOCS 3 signal
    Cong Wang, Jihuan Dai, Mengliu Yang, Guangjiang Deng, Shengnan Xu, Yanjun Jia, Guenther H. Boden, Zhongmin A. Ma, Gangyi Yang, Ling Li · 2014 · FEBS Journal
  7. Circulating Fibroblast Growth Factor 21 (Fgf21) as Diagnostic and Prognostic Biomarker in Renal Cancer
    María Elena Knott, José Nicolas Minatta · 2016 · Journal of Molecular Biomarkers & Diagnosis
  8. Olanzapine-depot administration induces time-dependent changes in adipose tissue endocrine function in rats
    Kateřina Horská, Jana Kučerová, Zuzana Babinská, Michal Karpíšek, Regina Demlová, Radka Opatřilová, Pavel Suchý, Hana Kotolová · 2016 · Psychoneuroendocrinology
  9. FGF21 deficiency is associated with childhood obesity, insulin resistance and hypoadiponectinaemia: The BCAMS Study
    Guo-Hung Li, Jingdong Yin, Junling Fu, Longcan Li, Struan F.A. Grant, Zhongxia Li, M. Li, Jie Mi, M. Li, Shan Gao · 2017 · Diabetes & Metabolism
  10. Early increases in serum FGF21 levels predict mortality of septic patients
    Xing Li, Zexiang Zhu, Tinghong Zhou, Xiaoyu Cao, Ting Lu, Yan Liang, Jiafen He, Chuankai Liu, Zhoulin Dou, Bin Shen · 2018 · Cytokine
  11. Fibroblast Growth Factor 21 in Patients with Cardiac Cachexia: A Possible Role of Chronic Inflammation
    Maria Refsgaard Holm, H. Christensen, Jon Rasmussen, Marie Louise Johansen, Morten Schou, Jens Oscar Faber, Caroline Kistorp · 2019 · ESC Heart Failure
  12. Fibroblast growth factor 21: a promising therapeutic target in obesity-related diseases
    Bernard M.Y. Cheung, HB Deng · 2014 · Expert Review of Cardiovascular Therapy
  13. Circulating Fibroblast Growth Factor 21 Is A Sensitive Biomarker for Severe Ischemia/reperfusion Injury in Patients with Liver Transplantation
    Dewei Ye, Huating Li, Yudong Wang, Weiping Jia, Jian Zhou, Jia Fan, Kwan Man, Chung‐Mau Lo, Chi‐Ming Wong, Yu Wang et al. · 2016 · Scientific Reports
  14. Impact of aging and caloric restriction on fibroblast growth factor 21 signaling in rat white adipose tissue
    Namiki Fujii, Seira Uta, Masaki Kobayashi, Tsugumichi Sato, Naoyuki Okita, Yoshikazu Higami · 2019 · Experimental Gerontology
  15. The Ablation of Mitochondrial Protein Phosphatase Pgam5 Confers Resistance Against Metabolic Stress
    Shiori Sekine, Yao Akari, Kazuki Hattori, Sho Sugawara, Isao Naguro, Masato Koike, Yasuo Uchiyama, Kohsuke Takeda, Hidenori Ichijo · 2016 · EBioMedicine
  16. Glucagon and Insulin Cooperatively Stimulate Fibroblast Growth Factor 21 Gene Transcription by Increasing the Expression of Activating Transcription Factor 4
    Kimberly M. Alonge, Gordon P. Meares, F. Bradley Hillgartner · 2017 · Journal of Biological Chemistry
  17. Higher serum levels of fibroblast growth factor 21 in old patients with cachexia
    K. Franz, Mario Ost, Lindsey Otten, Catrin Herpich, Verena Coleman, Anne–Sophie Endres, Susanne Klaus, Ursula Müller‐Werdan, Kristina Norman · 2018 · Nutrition
  18. Association of plasma FGF21 levels with muscle mass and muscle strength in a national multicentre cohort study: Korean Frailty and Aging Cohort Study
    Eun Roh, Soon Young Hwang, Hye Jin Yoo, Sei Hyun Baik, Belong Cho, Yong Soon Park, Hyeon Ju Kim, Sam‐Gyu Lee, Bong‐Jo Kim, Hak Chul Jang et al. · 2021 · Age and Ageing
  19. Fibroblast growth factor 21 and bone homeostasis
    Yan Tang, Mei Zhang · 2022 · Biomedical Journal
  20. Relationship of fibroblast growth factor 21 with baseline and new on-study microvascular disease in the Fenofibrate Intervention and Event Lowering in Diabetes study
    on behalf of the FIELD study investigators, Kwok Leung Ong, Andrzej S. Januszewski, Rachel L O'Connell, Luke Buizen, Alicia Josephine Jenkins, Aimin Xu, DAVID R. SULLIVAN, Philip J. Barter, Russell S. Scott et al. · 2015 · Diabetologia
  21. Anti-inflammatory effects of exercise training in adipose tissue do not require FGF21
    Jay W. Porter, Joe L. Rowles, Justin A. Fletcher, Terese M. Zidon, Nathan C. Winn, Leighton McCabe, Young-Min Park, James W. Perfield, John P. Thyfault, R. Scott Rector et al. · 2017 · Journal of Endocrinology
  22. Circulating FGF21 Concentration, Fasting Plasma Glucose, and the Risk of Type 2 Diabetes: Results From the PREVEND Study
    Adrian Post, Wendy Dam, Sara Sokooti, Dion Groothof, Jolein Gloerich, Alain J. van Gool, Daan Kremer, Ron T. Gansevoort, Jacob van den Born, Ido P. Kema et al. · 2022 · The Journal of Clinical Endocrinology & Metabolism
  23. Mechanistic insights into the liver–brain axis during chronic liver disease
    Matthew R. Siddle, Rocío Gallego Durán, Deepika Goel, Benjamin J. Renquist, Marie K. Holt, Anna Hadjihambi · 2025 · Nature Reviews Gastroenterology & Hepatology
  24. FGF21 as a Therapeutic Reagent
    Yang Zhao, James D. Dunbar, Alexei Kharitonenkov · 2012 · Advances in experimental medicine and biology
  25. The role of FGF21 in type 1 diabetes and its complications
    Jian Zhang, Wenya Weng, Kai Wang, Xuemian Lu, Lu Cai, Jian Sun · 2018 · International Journal of Biological Sciences
  26. Prolonged Glucagon Infusion Does Not Affect Energy Expenditure in Individuals with Overweight/Obesity: A Randomized Trial
    Whytock, Katie L., Carnero, Elvis A., Vega, Rick B., Tillner, Joachim, Bock, Christopher, Chivukula, Karthik, Yi, Fanchao, Meyer, Christian, Smith, Steven R., Sparks, Lauren M. · 2021 · Obesity
  27. Effects of Short-Term Continuous Subcutaneous Insulin Infusion on Fasting Plasma Fibroblast Growth Factor-21 Levels in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
    Mengliu Yang, Jing Dong, Hua Liu, Ling Li, Gangyi Yang · 2011 · PLoS ONE
  28. Evaluation of concentrations of FGF-21 - a new adipocytokine in type 2 diabetes.
    Beata Matuszek, Monika Lenart-Lipińska, Dariusz Duma, Janusz Solski, Andrzej Marcin Nowakowski · 2010 · PubMed
  29. Loss of FGF21 in diabetic mouse during hepatocellular carcinogenetic transformation.
    Quan Zhang, Li Yan, Tingting Liang, Xuemian Lu, Xingkai Liu, Chi Zhang, Xin Mei Jiang, Robert C.G. Martin, Mingliang Cheng, Lu Cai · 2015 · Europe PMC (PubMed Central)
  30. Basic fibroblast growth factor combined with extracellular matrix-inspired mimetic systems for effective skin regeneration and wound healing
    Donghui Bian, Yan Qing Wu, Guodong Song · 2023 · Materials Today Communications
  31. Association of elevated circulating fibroblast growth factor 21 levels with prevalent and incident metabolic syndrome: The Multi-Ethnic Study of Atherosclerosis
    Kwok Leung Ong, Robyn L. McClelland, Matthew Allison, John Kokkinos, Ben J. Wu, Philip J. Barter, Kerry‐Anne Rye · 2018 · Atherosclerosis
  32. Epigenome-wide association study of diet quality in the Women’s Health Initiative and TwinsUK cohort
    Whitney L. Do, Eric A. Whitsel, Ricardo Costeira, Olatz M. Masachs, Caroline Ivanne Le Roy, Jordana T. Bell, Lisa R. Staimez, Aryeh D. Stein, Alicia K. Smith, Steve Horvath et al. · 2020 · International Journal of Epidemiology
  33. The Multiple Roles of Fibroblast Growth Factor in Diabetic Nephropathy
    Junyu Deng, Ye Liu, Yi-Qiu Liu, Wei Li, Xu-Qiang Nie · 2021 · Journal of Inflammation Research
  34. Increased plasma CXCL16 levels in patients with chronic kidney diseases
    Zhuofeng Lin, Qi Gong, Zhihong Zhou, Weixing Zhang, Shixian Liao, Yanlong Liu, Xinxin Yan, Xuebo Pan, Shaoqiang Lin, Xiaokun Li · 2011 · European Journal of Clinical Investigation
  35. Increased Responses to the Actions of Fibroblast Growth Factor 21 on Energy Balance and Body Weight in a Seasonal Model of Adiposity
    M. Murphy, Ricardo J. Samms, Amy Warner, Matei Bolborea, Perry Barrett, Maxine J Fowler, John Michael Brameld, Kostas Tsintzas, Alexei Kharitonenkov, Andrew Charles Adams et al. · 2012 · Journal of Neuroendocrinology
  36. α-Lipoic acid as a triglyceride-lowering nutraceutical
    Anjeza Pashaj, Mengna Xia, Régis F. Moreau · 2015 · Canadian Journal of Physiology and Pharmacology
  37. Relationship of fibroblast growth factor 21 levels with inflammation, lipoproteins and non-alcoholic fatty liver disease
    Bradley Tucker, Robyn L. McClelland, Matthew Allison, Matthew Jay Budoff, Ben J. Wu, Philip J. Barter, Kerry‐Anne Rye, Kwok Leung Ong · 2020 · Atherosclerosis
  38. Fibroblast growth factor 21 is expressed and secreted from skeletal muscle following electrical stimulation via extracellular ATP activation of the PI3K/Akt/mTOR signaling pathway
    Manuel Arias‐Calderón, Mariana Casas, Julián Balanta‐Melo, Camilo Morales, Nadia Hernández, Paola Llanos, Enrique Jaimovich, Sonja Buvinic · 2023 · Frontiers in Endocrinology
  39. Intestinal FGF15 regulates bile acid and cholesterol metabolism but not glucose and energy balance
    Nadejda Bozadjieva-Kramer, Jae Hoon Shin, Ziru Li, Alan C. Rupp, Nicole Miller, Stace Kernodle, Nicolas Lanthier, Paulina Henry, Nikhil Seshadri, Andriy Myronovych et al. · 2024 · JCI Insight
  40. Reduction in serum fibroblast growth factor-21 after gastric bypass is related to changes in hepatic fat content
    Karen Fjeldborg, Steen B. Pedersen, Holger Jon Møller, Bjørn Richelsen · 2017 · Surgery for Obesity and Related Diseases
  41. Short‐term protein restriction at advanced age stimulates FGF21 signalling, energy expenditure and browning of white adipose tissue
    Marleen B. Dommerholt, Maaike Blankestijn, Marcel A. Vieira‐Lara, Theo H. van Dijk, Henk Wolters, Mirjam H. Koster, Albert Gerding, Ronald P. van Os, Vincent W. Bloks, Barbara M. Bakker et al. · 2020 · FEBS Journal
  42. Levels of β-klotho determine the thermogenic responsiveness of adipose tissues: involvement of the autocrine action of FGF21
    Ricardo Moure, Montserrat Cairó, Samantha Morón‐Ros, Tania Quesada‐López, Laura Campderrós, Rubén Cereijo, Álvaro Hernáez, Francesc Villarroya, Marta Giralt · 2021 · American Journal of Physiology-Endocrinology and Metabolism
  43. Pancreatic Islet Responses to Metabolic Trauma
    Susan J. Burke, Michael D. Karlstad, J. Jason Collier · 2016 · Shock
  44. Omega 3 rich diet modulates energy metabolism via GPR120-Nrf2 crosstalk in a novel antioxidant mouse model
    Deborah Amos, Carla R. Cook, Nalini Santanam · 2019 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  45. The FGF21 response to fructose predicts metabolic health and persists after bariatric surgery in obese humans
    Kasper W. ter Horst, Pim W. Gilijamse, Ahmet Demirkıran, Bart A. van Wagensveld, Mariëtte T. Ackermans, Joanne Verheij, Johannes Anthonius Romijn, Max Nieuwdorp, Eleftheria Maratos–Flier, Mark A. Herman et al. · 2017 · Molecular Metabolism
  46. The Speed of Ingestion of a Sugary Beverage Has an Effect on the Acute Metabolic Response to Fructose
    Mehmet Kanbay, Begüm Güler Şentürk, Lale A. Ertuğlu, Tuncay Dağel, Barış Afşar, Said İncir, Arzu Baygül, Adrian Constantin Covic, Ana Andrés-Hernando, Laura Gabriela Sánchez‐Lozada et al. · 2021 · Nutrients
  47. Albumin-fused long-acting FGF21 analogue for the treatment of non-alcoholic fatty liver disease
    Mayuko Chikamatsu, Hiroshi Watanabe, Yuhi Shintani, Ryota Murata, Masako Miyahisa, Ayano Nishinoiri, Tadashi Imafuku, Mei Takano, Nanaka Arimura, Koh‐ichi Yamada et al. · 2023 · Journal of Controlled Release
  48. Molecular Characterization and Mapping of Fgf21 Gene in a Foodfish Species Asian Seabass
    Le Wang, Jun Xia, Xiaojun Liu, Peng Liu, Zi Yi Wan, Gen Hua Yue · 2014 · PLoS ONE
  49. Lower Cerebrospinal Fluid/Plasma Fibroblast Growth Factor 21 (FGF21) Ratios and Placental FGF21 Production in Gestational Diabetes
    Bee Kang Tan, Kavitha Sivakumar, Muhammad Furqan Bari, Manu Vatish, Harpal Singh Randeva · 2013 · PLoS ONE
  50. Fibroblast Growth Factor 21: A Novel Metabolic Regulator
    Ji A Seo, Nan Hee Kim · 2012 · Diabetes & Metabolism Journal
  51. Serum FGF21 Levels in Obese Korean Children and Adolescents
    Joonwoo Baek, Hyo‐Kyoung Nam, Young‐Jun Rhie, Kee‐Hyoung Lee · 2017 · Journal of Obesity & Metabolic Syndrome
  52. The role of fibroblast growth factor 21 in the pathogenesis of liver disease: a novel predictor and therapeutic target
    Wen‐Yue Liu, Sha Huang, Keqing Shi, Chenchen Zhao, Li-Li Chen, Martin Braddock, Yongping Chen, Wenke Feng, Ming‐Hua Zheng · 2014 · Expert Opinion on Therapeutic Targets
  53. Effects of deficiency of Kelch‐like ECH‐associated protein 1 on skeletal organization: a mechanism for diminished nuclear factor of activated T cells cytoplasmic 1 during osteoclastogenesis
    Eiko Sakai, Masanobu Morita, Masahiro Ohuchi, Mizuho A. Kido, Yutaka Fukuma, Kazuhisa Nishishita, Kuniaki Okamoto, Ken Itoh, Masayuki P. Yamamoto, Takayuki Tsukuba · 2017 · The FASEB Journal
  54. Increased plasma FGF21 level as an early biomarker for insulin resistance and metabolic disturbance in obese insulin-resistant rats
    Pongpan Tanajak, Wanpitak Pongkan, Siriporn Chaisin Chattipakorn, Nipon Chattipakorn · 2018 · Diabetes and Vascular Disease Research
  55. Improving hyperglycemic effect of FGF‐21 is associated with alleviating inflammatory state in diabetes
    Nan Wang, Tong-yu Xu, Xu Zhang, Jun-Yan Li, Yun-Xin Wang, Xiao-Chen Guo, Si-Ming Li, Wen-Fei Wang, De-Shan Li · 2018 · International Immunopharmacology
  56. Relationship of Selected Adipokines with Markers of Vascular Damage in Patients with Type 2 Diabetes
    Jaromíra Spurná, David Karásek, Veronika Kučerová, Dominika Goldmannová, Ondřej Krystyník, Jan Schovánek, Josef Zadražil · 2018 · Metabolic Syndrome and Related Disorders
  57. Effect of sleeve gastrectomy on plasma growth differentiation factor-15 (GDF15) in human
    Ponnie Robertlee Dolo, Libin Yao, Peng Peng Liu, Jason Widjaja, Meng Song, Chao Li, Xiaocheng Zhu · 2020 · The American Journal of Surgery
  58. Mistranslation Drives Alterations in Protein Levels and the Effects of a Synonymous Variant at the Fibroblast Growth Factor 21 Locus
    Ali Bayoumi, Asmaa Elsayed, Shuanglin Han, Salvatore Petta, Leon Anton Adams, R. Aller, Anis Khan, Carmelo García‐Monzón, M. Arias, Luca Miele et al. · 2021 · Advanced Science
  59. Cord blood FGF21 in gestational diabetes and its relationship with postnatal growth
    Ana Megía, Pilar Gil-Lluís, Sílvia Näf, Victòria Ceperuelo‐Mallafré, José Miguel González-Clemente, Gemma Llauradó, Catalina Núñez‐Roa, Kelly Roche, Mónica Ballesteros, Rosa Elena Yañez et al. · 2015 · Acta Diabetologica
  60. Translational Pharmacology and Physiology of Brown Adipose Tissue in Human Disease and Treatment
    Christopher J. Larson · 2018 · Handbook of experimental pharmacology
  61. Relationship of fibroblast growth factor 21 with subclinical atherosclerosis and cardiovascular events: Multi-Ethnic Study of Atherosclerosis
    Kwok Leung Ong, Steven Campbell, Ben J. Wu, Robyn L. McClelland, John Kokkinos, Moysés Szklo, Joseph F. Polak, Matthew Allison, K.-A. Rye · 2019 · Atherosclerosis
  62. FGF21-FGFR4 signaling in cardiac myocytes promotes concentric cardiac hypertrophy in mouse models of diabetes
    Christopher Yanucil, Dominik Kentrup, Xueyi Li, Alexander Grabner, Karla J. Schramm, Eliana C. Martinez, Jinliang Li, Isaac D. Campos, Brian A. Czaya, Kylie Heitman et al. · 2022 · Scientific Reports
  63. Crucial Regulatory Role of Organokines in Relation to Metabolic Changes in Non-Diabetic Obesity
    Hajnalka Lőrincz, Sándor Somodi, Balázs Ratku, Mariann Harangi, György Paragh · 2023 · Metabolites
  64. Fibroblast Growth Factor‐21 and the Beneficial Effects of Long‐Chain n‐3 Polyunsaturated Fatty Acids
    Joan Villarroya, Pavel Flachs, Ibon Redondo‐Angulo, Marta Giralt, Daša Medříková, Francesc Villarroya, Ján Kopecký, Anna Planavila · 2014 · Lipids
  65. Serum fibroblast growth factor 21 in human obesity: regulation by insulin infusion and relationship with glucose and lipid oxidation
    Marek Strączkowski, Monika Karczewska‐Kupczewska, Agnieszka Adamska, Elżbieta Otziomek, Irina Kowalska, Agnieszka Nikołajuk · 2013 · International Journal of Obesity
  66. Effect of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) on Hormones of Energy Balance in a TCDD-Sensitive and a TCDD-Resistant Rat Strain
    Jere Lindén, Sanna Lensu, Raimo Pohjanvirta · 2014 · International Journal of Molecular Sciences
  67. Nonalcoholic Fatty Liver Disease
    Samer Gawrieh · 2016 · Springer eBooks
  68. Role of fibroblast growth factor 21 in gestational diabetes mellitus: A mini‐review
    Daniel Yuan, Ben J. Wu, Amanda Henry, Kerry‐Anne Rye, Kwok Leung Ong · 2018 · Clinical Endocrinology
  69. Endocrine Fibroblast Growth Factors in Relation to Stress Signaling
    Makoto Shimizu, Ryuichiro Sato · 2022 · Cells
  70. Biomarkers in metabolic syndrome
    Young Hye Cho, Youngin Lee, Jung In Choi, Sae Rom Lee, Sang Yeoup Lee · 2022 · Advances in clinical chemistry
  71. Circulating FGF21 levels are related to nutritional status and metabolic but not hormonal disturbances in polycystic ovary syndrome
    Magdalena Olszanecka‐Glinianowicz, Paweł Madej, Michał Wdowczyk, Aleksander Jerzy Owczarek, Jerzy Tadeusz Chudek · 2014 · European Journal of Endocrinology
  72. Nutritional regulation of fibroblast growth factor 21: from macronutrients to bioactive dietary compounds
    Albert Pérez‐Martí, Viviana Sandoval, Pedro F. Marrero, Diego Haro, Joana Relat · 2016 · Hormone Molecular Biology and Clinical Investigation
  73. Roux-en-Y gastric bypass surgery is effective in fibroblast growth factor-21 deficient mice
    Christopher D. Morrison, Hao Zheng, Michael B. Mumphrey, R. Leigh Townsend, Heike Münzberg, Jianping Ye, Hans‐Rudolf Berthoud · 2016 · Molecular Metabolism
  74. Fasting decreases plasma FGF21 in obese subjects and the expression of FGF21 receptors in adipose tissue in both lean and obese subjects
    Eva B. Nygaard, Cathrine Ørskov, Thomas Almdal, Henrik Vestergaard, Birgitte Andersen · 2018 · Journal of Endocrinology
  75. Aerobic exercise for eight weeks provides protective effects towards liver and cardiometabolic health and adipose tissue remodeling under metabolic stress for one week: A study in mice
    Youn Ju Kim, Hye Jin Kim, Sang Gyu Lee, Do Hyun Kim, Su Jang, Hye Sun Go, Won Jun Lee, Je Kyung Seong · 2022 · Metabolism
  76. The relationship between sarcopenia detected in newly diagnosed colorectal cancer patients and FGF21, irisin and CRP levels
    Utku Oflazoğlu, Sevinc Cağlar, Huriye Erbak Yılmaz, Hülya Tas Önal, Umut Varol, Tarık Salman, Yaşar Yıldız, Sinan Ünal, Zeynep Gülsüm Güç, Yüksel Küçükzeybek et al. · 2022 · European Geriatric Medicine
  77. Metabolic Effects of FGF-21: Thermoregulation and Beyond
    Bin Ni, Jared S. Farrar, Janina A. Vaitkus, Francesco Saverio Celi · 2015 · Frontiers in Endocrinology
  78. Non-sympathetic control of brown adipose tissue
    Rubén Cereijo, Joan Villarroya, Francesc Villarroya · 2015 · International Journal of Obesity Supplements
  79. N-3 polyunsaturated fatty acids increase hepatic fibroblast growth factor 21 sensitivity via a PPAR-γ-β-klotho pathway
    Wenqi Yang, Xu Chen, Yan Liu, Ming Chen, Xinwei Jiang, Tianran Shen, Qing Li, Yan Yang, Wenhua Ling · 2017 · Molecular Nutrition & Food Research
  80. Fibroblast growth factor 21 association with subclinical atherosclerosis and arterial stiffness in type 2 diabetes
    Saeed Yafei, Fathy Zakrea El-sewy, Eman Ahmed Youssef, Mohammed Ayman, Mohamed Nabil Elshafei · 2018 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
  81. Membraneless reproducible MoS2 field-effect transistor biosensor for high sensitive and selective detection of FGF21
    Xinxing Gong, Yeru Liu, Haiyan Xiang, Hang Liu, Zhigang Liu, Xiaorui Zhao, Jishan Li, Huimin Li, Guo Hong, Travis Shihao Hu et al. · 2019 · Science China Materials
  82. Fibroblast growth factor signaling in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Paving the way to hepatocellular carcinoma
    Matthias Ocker · 2020 · World Journal of Gastroenterology
  83. Liraglutide Decreases Liver Fat Content and Serum Fibroblast Growth Factor 21 Levels in Newly Diagnosed Overweight Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
    Xinyue Li, Xiaojuan Wu, Yumei Jia, Jing Fu, Lin Zhang, Tao Jiang, Jia Liu, Guang Wang · 2021 · Journal of Diabetes Research
  84. Serum FGF21 and RBP4 levels in patients with chronic hepatitis C
    Michał Kukla, Agnieszka Berdowska, Dominika Marta Stygar, Andrzej Gabriel, Włodzimierz Mazur, Beata Łogiewa-Bazger, Barbara Sobala‐Szczygieł, Rafał Jakub Bułdak, Maria Rokitka, Wojciech Zajęcki et al. · 2012 · Scandinavian Journal of Gastroenterology
  85. Association of fibroblast growth factor (FGF-21) as a biomarker with primary mitochondrial disorders, but not with secondary mitochondrial disorders (Friedreich Ataxia)
    Mohammad Hossein Salehi, Behnam Kamalıdehghan, Massoud Houshmand, Omid Aryani, Majid Sadeghizadeh, Mir Majid Mossalaeie · 2013 · Molecular Biology Reports
  86. The interplay between birth weight and obesity in determining childhood and adolescent cardiometabolic risk
    Sara Elizabeth Stinson, Pauline Kromann Reim, Morten Asp Vonsild Lund, Ulrik Lausten‐Thomsen, Louise Aas Holm, Yun Huang, Charlotte Brøns, Allan Arthur Vaag, Maja Sofie Thiele, Aleksander Ahm Krag et al. · 2024 · EBioMedicine
  87. Targeting fibroblast growth factor (FGF)-21: a promising strategy for metabolic dysfunction-associated steatotic liver disease treatment
    Xinyue Cui, Quanhao Sun, Haiqiang Wang · 2025 · Frontiers in Pharmacology
  88. Novel Molecules Regulating Energy Homeostasis: Physiology and Regulation by Macronutrient Intake and Weight Loss
    Anna Gavrieli, Christos Socrates Mantzoros · 2016 · Endocrinology and Metabolism
  89. C1q/TNF-related Protein 1, a Multifunctional Adipokine: An Overview of Current Data
    Joanna Janowska · 2020 · The American Journal of the Medical Sciences
  90. Effects of Exercise Intervention on Mitochondrial Stress Biomarkers in Metabolic Syndrome Patients: A Randomized Controlled Trial
    Jae Seung Chang, Jun Namkung · 2021 · International Journal of Environmental Research and Public Health
  91. Long-Term Dietary Taurine Lowers Plasma Levels of Cholesterol and Bile Acids
    Ryoma Tagawa, Masaki Kobayashi, Misako Sakurai, Maho Yoshida, Hiroki Kaneko, Yuhei Mizunoe, Yuka Nozaki, Naoyuki Okita, Yuka Sudo, Yoshikazu Higami · 2022 · International Journal of Molecular Sciences
  92. Reduced Levels of Serum FGF19 and Impaired Expression of Receptors for Endocrine FGFs in Adipose Tissue From HIV-Infected Patients
    José Miguel Gallego-Escuredo, Peré Domingo, María del Mar Gutiérrez, Gracia María Mateo, Maria C. Cabeza, Àngels Fontanet, Francesc Vidal, Joan Carles Domingo, Marta Giralt, Francesc Villarroya · 2012 · JAIDS Journal of Acquired Immune Deficiency Syndromes
  93. Exenatide treatment decreases fasting fibroblast growth factor 21 levels in patients with newly diagnosed type 2 diabetes mellitus
    Yanjin Hu, June Liu, H. Zhang, Yuan Xu, Tianpei Hong, Gang Wang · 2016 · Diabetes & Metabolism
  94. Fibroblast growth factor 21 regulates lipid accumulation and adipogenesis in goat intramuscular adipocyte
    Qing Xu, Sen Lin, Qian Li, Yaqiu Lin, Yan Xiong, Jiangjiang Zhu, Yong Wang · 2019 · Animal Biotechnology
  95. Effects of sodium-glucose cotransporter 2 inhibitor (dapagliflozin) on food intake and plasma fibroblast growth factor 21 levels in type 2 diabetes patients
    Rieko Kosugi, Eiji Nakatani, Kensuke Okamoto, Saeko Aoshima, Hidekazu Arai, Tatsuhide Inoue · 2019 · Endocrine Journal
  96. Circulating Adipokines and Associations With Incident Cardiovascular Disease in Rheumatoid Arthritis
    Lydia E. Federico, Tate M. Johnson, Bryant R. England, Katherine D. Wysham, Michael George, Brian C. Sauer, Bartlett C. Hamilton, Carlos D. Hunter, Michael J. Duryee, Geoffrey M. Thiele et al. · 2022 · Arthritis Care & Research
  97. Comparing the effects of nano-sized sugarcane fiber with cellulose and psyllium on hepatic cellular signaling in mice
    Wang, Yu, Zhang, Z. Elizabeth Floyd, Lian, Cefalu, Boudreau · 2012 · International Journal of Nanomedicine
  98. A Serum Component Mediates Food Restriction–Induced Growth Attenuation
    Rakefet Pando, Biana Shtaif, Moshe Phillip, Galia Gat‐Yablonski · 2014 · Endocrinology
  99. Hepatic FGF21 production is increased in late pregnancy in the mouse
    Yingjun Cui, Sarah L. Giesy, Mahmoud Hassan, Kristen Davis, Shuhong Zhao, Yves R. Boisclair · 2014 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
  100. Fibroblast Growth Factor 21 Levels in Young Healthy Females Display Day and Night Variations and Are Increased in Response to Short-Term Energy Deprivation Through a Leptin-Independent Pathway
    Joo‐Pin Foo, Konstantinos N. Aronis, John P. Chamberland, Jason Paruthi, Hyun‐Seuk Moon, Christos Socrates Mantzoros · 2012 · Diabetes Care